40 Psychiatrists Lobby FDA to Legitimize Drug Restraints for Aggression

40 Psychiatrists Lobby FDA to Legitimize Drug Restraints for Aggression Mon, 21 Mar 2005 At first glance, a Newsday article–Hot Under the Collar?– might appear as a hilarious parody of bio-psychiatry. It is not. “Recently, 40 scientists met with two FDA officials to make a case for testing treatments specifically…

Prescriptions And Profit_CBS News 60 Minutes Tue, 16 Mar 2004

Prescriptions And Profit_CBS News 60 Minutes Tue, 16 Mar 2004 “Americans pay far more for their prescription drugs than citizens of any place on Earth.” That’s because “The United States is the only industrialized country without some form of control on the prices of drugs.” No wonder the U.S. accounts…

Medication switched for research purposes – patient nearly dies

Medication switched for research purposes – patient nearly dies Tue, 11 Nov 2003 The Boston Globe reports that an investigation by a state oversight agency, “uncovered numerous ethical violations at the Solomon Carter Fuller Mental Health Center by Boston Medical Center physicians contracted to treat patients there.” Boston University Medical…

Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ

Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 The Wall Street Journal uncritically reported: “The results of the largest studies ever conducted of depression and schizophrenia will be released in coming months, potentially transforming the way patients are treated and shaking…

| | |

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising

AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00….

GlaxoSmithKline CEO: "We had to absorb a number of hits"

GlaxoSmithKline CEO: “We had to absorb a number of hits” Mon, 16 Feb 2004 Antidepressant drug safety issues are beginning to have a financial impact. Dow Jones reports: “GlaxoSmithKline PLC said its net income fell 6% in the fourth quarter, hurt by previously announced legal costs related to its anti-inflammatory…

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT

Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…

| | |

Corporate influence on medicine, budgets & investors

July 14, 2002 Corporate Influence on Medicine, Healthcare Budgets, Investors FYI Because medicine’s pronouncements are so widely propagated and affect so many people’s lives, corporate influence and manipulation of the truth is more devastating than mere corporate accounting malfeasance. Recent revelations demonstrate how corporate influence and greed – rather than…

China Daily investigation challenges US genetic experiments on poor farmers

China Daily A farming family’s recollection 2003-09-25 http://www1.chinadaily.com.cn/en/doc/2003-09/25/content_267233.htm Near-death experience after 55-year-old father of four inhales ‘fog-like’ spray China Features reporters XIONG LEI and WEN CHIHUA recently visited Zongyang County, in East China’s Anhui Province, to further dig into the allegations surrounding Harvard’s genetic studies in China. Their investigation was…